Latest metronidazole Stories

2009-04-21 08:00:00

Results Reveal Rosacea's Emotional and Social Impact on Patients, Prompting Beauty Expert Charla Krupp and Expert Dermatologist, Dr.

2009-03-25 05:30:00

- Up to $50 Million Potential Milestones plus Double Digit Royalties on Future Sales - - Company to Host Conference Call at 11:00 a.m. ET Today - EMERYVILLE, Calif., March 25 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc.

2009-03-03 14:17:17

Resent studies reported that aspirin inhibited the growth of H. pylori in a dose-dependent manner and significantly affected the activity of virulence factors of H. pylori.

2009-02-03 08:30:00

FORT WORTH, Texas, Feb. 3 /PRNewswire/ -- Galderma Laboratories, L.P. today announced that the U.S.

2009-02-03 07:00:00

SAN ANTONIO, Feb. 3 /PRNewswire/ -- BioComp Pharma, Inc. launched Tinidazole 500, the first generic version of the FDA-approved drug Tindamax(R). Tindamax(R) is the only oral antimicrobial drug approved by the FDA for the treatment of both trichomoniasis (trich) and bacterial vaginosis (BV).

2009-01-06 08:30:00

Epiduo(TM) Gel Combines Retinoid and Benzoyl Peroxide in a Single Product; Performs Better than Either Component Alone FORT WORTH, Texas, Jan. 6 /PRNewswire/ -- Galderma Laboratories, L.P.

2008-11-12 12:00:00

According to Optimer Pharmaceuticals, its lead anti-infective drug candidate, OPT-80, showed higher clinical cure, global cure and recurrence rates in Phase III trials for the treatment of Clostridium difficile than the current standard of care, Vancocin.

2008-11-10 18:00:22

Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today released positive top-line results from a pivotal Phase 3 clinical study of the Company's lead anti-infective drug candidate, OPT-80, in patients with Clostridium difficile Infection (CDI).

2008-08-26 03:00:17

By Chaudhry, Rama Joshy, Lovely; Kumar, Lalit; Dhawan, Benu Background & objectives: Frequent use of broad spectrum antibiotics in hospitalized patients has increased the incidence of Clostridium difficile diarrhoea in recent years. In our tertiary care hospital in north India, C.

2008-07-16 21:00:28

LAUSANNE, Switzerland, July 16 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, announced today that Japan's Ministry of Health, Labor and Welfare has approved Differin(R) Gel 0.1% (adapalene), a novel topical treatment for acne vulgaris in Japan.

Word of the Day
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.